Public Library of Science
Browse
pone.0215292.g001.tif (246.89 kB)

Survival curves of EGFR-mutated NSCLC patients treated with nivolumab.

Download (246.89 kB)
figure
posted on 2019-04-12, 17:33 authored by Miyuki Sato, Satoshi Watanabe, Hiroshi Tanaka, Koichiro Nozaki, Masashi Arita, Miho Takahashi, Satoshi Shoji, Kosuke Ichikawa, Rie Kondo, Nobumasa Aoki, Masachika Hayashi, Yasuyoshi Ohshima, Toshiyuki Koya, Riuko Ohashi, Yoichi Ajioka, Toshiaki Kikuchi

(A) Progression-free survival and (B) overall survival of patients treated with nivolumab.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    densityPD-L 1 expressionHRtype EGFR NSCLCsnivolumabtumor microenvironmentNSCLC patientsepidermal growth factor receptornon-small-cell lung cancersEGFR mutationsNAEGFR-tyrosine kinase inhibitorsprogression-free survivalCD 4CIcell death 1T cellsFoxp 3biomarker

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC